We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Drager Medical

Drager Medical manufactures anesthesia workstations, medical ventilation, patient monitoring as well as neonatal care... read more Featured Products: More products

Download Mobile App




Critical Illness Leads to Accelerated Muscle Wasting

By HospiMedica International staff writers
Posted on 25 Jun 2014
Print article
Image: Dr. Zudin Puthucheary, Anne Pattinson, and Prof. Andreas Hoeft at the ESA award ceremony (Photo courtesy of Dräger).
Image: Dr. Zudin Puthucheary, Anne Pattinson, and Prof. Andreas Hoeft at the ESA award ceremony (Photo courtesy of Dräger).
The 2014 European Society of Anaesthesiology (ESA) Dräger prize in anesthesia and intensive care was awarded to Zudin Puthucheary, MD, who represented University College London (UCL; United Kingdom), for their study on acute skeletal muscle wasting in critical illness.

Dr Puthucheary and his group of researchers at the UCL Institute of Health and Human Performance were awarded the EUR 10,000 prize for their comprehensive characterization study of skeletal muscle wasting in 63 critically ill patients (59% male; mean age: 54.7 years). The patients were prospectively recruited within 24 hours following intensive care unit (ICU) admission (from August 2009 to April 2011). The patients were recruited if they were anticipated to be intubated for longer than 48 hours, to spend more than 7 days in critical care, and to survive ICU stay.

Muscle loss was determined through serial ultrasound measurement of the rectus femoris cross-sectional area (CSA) on days 1, 3, 7, and 10. In a subset of patients, the fiber CSA area was quantified along with the ratio of protein to DNA on days 1 and 7. Histopathological analysis, muscle protein synthesis, breakdown rates, and respective signaling pathways were also characterized. The researchers found that it took only three days in the hospital before the rectus femoris muscle mass of the study participants decreased significantly; the muscle wasting continued in the following days.

By day 10, rectus femoris CSA decreased by 10.3%, fiber CSA decreased by 17.5%, and the ratio of protein to DNA decreased by 29.5%. The decrease was greater in patients who experienced multiorgan failure compared to single organ failure. Leg protein breakdown remained elevated throughout the study, and the pattern of intracellular signaling supported a model of increased breakdown and decreased synthesis. Delivering more protein as nutrition did not lead to less muscle wasting. The study was first published online on October 9, 2013, in the Journal of the American Medical Association (JAMA).

The Dräger prize in anesthesia and intensive care was awarded by the chairman of the scientific committee of the ESA, Prof. Andreas Hoeft, MD, together with Anne Pattinson, marketing manager at Dräger (Lübeck, Germany) for UK and Ireland, at the opening of Euroanaesthesia 2014, held during June in Stockholm (Sweden).

Related Links:

University College London
Dräger


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultrasound Table
Women’s Ultrasound EA Table
New
Fixed Volume Dispense Pump
LPL Series

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.